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Background
The CD4-binding site (CD4bs) on gp120 is targeted by
broadly neutralizing antibodies (nAbs) and is therefore
of interest for vaccine design. Insight derived from
molecular interactions of CD4bs-specific antibodies with
gp120 has guided structure-based protein design and
the development of a number of immunogens. Of equal
interest are strategies to improve potency and durability
of desired nAb responses to such immunogens.
Methods
We generated truncated, hyperglycosylated gp120 mutants
designed to selectively present nAb epitopes overlapping
the CD4bs. To help focus antibody responses to these epi-
topes, we conducted a heterologous prime:boost immuni-
zation using two mutants (termed ΔN2mCHO and
ΔN2mCHO(Q105N)) in combination with a resurfaced
gp120 core protein (RSC3) that preferentially presents the
CD4bs neutralizing face. Groups of animals were primed
with ΔN2mCHO, unappended or N-terminally appended
with one of three immunostimulatory sequences known to
amplify humoral responses – PADRE, N10 or C3d. The
animals were boosted with RSC3 and then ΔN2mCHO
(Q105N). Serum specificities were dissected using CD4bs
and non-CD4bs mAbs and responses were followed at the
cellular level by phenotyping the memory B cell compart-
ment after each injection.
Results
Relative to other groups, PADRE-ΔN2mCHO elicited sig-
nificantly more rapid and higher titres against gp120 and
the immunogens, suggesting that PADRE has superior
immunoactivating properties. The PADRE- antibodies also
bound greatest to epitopes overlapping the CD4bs. Unex-
pectedly, only sera from N10- animals exhibited significant
neutralizing activity against select tier 1B and 2 viruses.
Unanticipatedly also, no significant differences were
observed at the memory B cell level between the groups
for gp120 specificity.
Conclusion
Our results show that selective exposure of conserved epi-
topes through the use of varied immunogens fused with
immunostimulatory sequences, in particular PADRE, can
boost desired antibody responses. Together, our data high-
light the importance of not only immunogen design but
also formulation on directing antibody responses to con-
served epitopes.
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